TQ Pharma held its second urology forum from May 15 to 22, with the participation of leading urologists.

Dr. Khalid As’sadiq, Consultant Urologist, delivered a valuable lecture that enriched discussions and promoted knowledge exchange.

At the closing, TQ Pharma announced the re-launch of the newly developed Prostanic XR for the treatment of BPH, reaffirming its commitment to advanced therapeutic solutions.

The forum took place at the Kempinski Hotel – Dead Sea and concluded successfully with strong positive engagement from participants, underscoring the value of such scientific events in fostering professional exchange.